Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels

Схожие документы

• Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
  по: Mihaylova, B, и др.
  Опубликовано: (2005)
• Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
  по: Mihaylova, B, и др.
  Опубликовано: (2005)
• Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.
  по: Mihaylova, B, и др.
  Опубликовано: (2006)
• Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
  по: Mihaylova, B, и др.
  Опубликовано: (2024)
• The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
  по: Kent, S, и др.
  Опубликовано: (2016)